BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34863091)

  • 1. IL4/IL4R signaling promotes the osteolysis in metastatic bone of CRC through regulating the proliferation of osteoclast precursors.
    Jin Q; Yang H; Jing Z; Hong-Hua W; Ben-Jing S; Li-Ting W; Li-Juan Y; Wei X; Xia K; Juan W; Wei Z
    Mol Med; 2021 Dec; 27(1):152. PubMed ID: 34863091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-325-3p, a novel regulator of osteoclastogenesis in osteolysis of colorectal cancer through targeting S100A4.
    Chengling L; Yulin Z; Xiaoyu X; Xingchen L; Sen Z; Ziming W; Xianming C
    Mol Med; 2021 Mar; 27(1):23. PubMed ID: 33691630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactic acid promotes metastatic niche formation in bone metastasis of colorectal cancer.
    Qian J; Gong ZC; Zhang YN; Wu HH; Zhao J; Wang LT; Ye LJ; Liu D; Wang W; Kang X; Sheng J; Xu W; Liu XL; Wu J; Zheng W
    Cell Commun Signal; 2021 Jan; 19(1):9. PubMed ID: 33478523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL7 playing a dominant role in recruiting early OCPs to facilitate osteolysis at metastatic site of colorectal cancer.
    Yang H; Jian L; Jin Q; Xia K; Cai-Ru W; Jun S; Chen H; Wei W; Ben-Jing S; Shi-Hong L; Shi-Wei L; Juan W; Wei Z
    Cell Commun Signal; 2022 Jun; 20(1):94. PubMed ID: 35715847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer cells promote osteoclastogenesis and bone destruction through regulating EGF/ERK/CCL3 pathway.
    Zi-Chen G; Jin Q; Yi-Na Z; Wei W; Xia K; Wei X; Juan W; Wei Z
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32478376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPR84 potently inhibits osteoclastogenesis and alleviates osteolysis in bone metastasis of colorectal cancer.
    Jian L; Shi-Wei L; Dan J; Juan W; Wei Z
    J Orthop Surg Res; 2023 Jan; 18(1):3. PubMed ID: 36593458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-7062-5p Promoting Bone Resorption After Bone Metastasis of Colorectal Cancer Through Inhibiting GPR65.
    Chen L; Wang Y; Lu X; Zhang L; Wang Z
    Front Cell Dev Biol; 2021; 9():681968. PubMed ID: 34485279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth.
    Venmar KT; Kimmel DW; Cliffel DE; Fingleton B
    Biochim Biophys Acta; 2015 May; 1853(5):1219-28. PubMed ID: 25746764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation.
    Yang C; Davis JL; Zeng R; Vora P; Su X; Collins LI; Vangveravong S; Mach RH; Piwnica-Worms D; Weilbaecher KN; Faccio R; Novack DV
    Cancer Discov; 2013 Feb; 3(2):212-23. PubMed ID: 23269702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade.
    Zhang L; Yang Y; Liao Z; Liu Q; Lei X; Li M; Saijilafu ; Zhang Z; Hong D; Zhu M; Li B; Yang H; Chen J
    Theranostics; 2020; 10(15):6638-6660. PubMed ID: 32550895
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysis.
    Marino S; Bishop RT; Logan JG; Mollat P; Idris AI
    Cancer Lett; 2017 Dec; 410():180-190. PubMed ID: 28965856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in the Number of Bone Marrow Osteoclast Precursors at Different Skeletal Sites, Particularly in Long Bone and Jaw Marrow in Mice Lacking IL-1RA.
    Ascone G; Cao Y; Jansen IDC; Di Ceglie I; van den Bosch MHJ; Blom AB; van Lent PLEM; Everts V; de Vries TJ
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
    Li Z; Xiao J; Wu X; Li W; Yang Z; Xie J; Xu L; Cai X; Lin Z; Guo W; Luo J; Liu M
    Curr Mol Med; 2012 Sep; 12(8):967-81. PubMed ID: 22574935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions.
    Movila A; Ishii T; Albassam A; Wisitrasameewong W; Howait M; Yamaguchi T; Ruiz-Torruella M; Bahammam L; Nishimura K; Van Dyke T; Kawai T
    J Bone Miner Res; 2016 Sep; 31(9):1688-700. PubMed ID: 27082509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.
    Marino S; Bishop RT; Mollat P; Idris AI
    Calcif Tissue Int; 2018 Aug; 103(2):206-216. PubMed ID: 29455416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
    Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
    Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease.
    Bendre MS; Montague DC; Peery T; Akel NS; Gaddy D; Suva LJ
    Bone; 2003 Jul; 33(1):28-37. PubMed ID: 12919697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross-species analysis of a mouse model of breast cancer-specific osteolysis and human bone metastases using gene expression profiling.
    Sadanandam A; Futakuchi M; Lyssiotis CA; Gibb WJ; Singh RK
    BMC Cancer; 2011 Jul; 11():304. PubMed ID: 21774828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
    Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
    Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292.
    Furugaki K; Moriya Y; Iwai T; Yorozu K; Yanagisawa M; Kondoh K; Fujimoto-Ohuchi K; Mori K
    Clin Exp Metastasis; 2011 Oct; 28(7):649-59. PubMed ID: 21688034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.